Skip to main content
Clinical Trials/NCT00853515
NCT00853515
Terminated
N/A

A Randomized-controlled Trial of a Targeted Approach to Fluid Resuscitation in Acute Pancreatitis

Brigham and Women's Hospital1 site in 1 country40 target enrollmentMarch 2009

Overview

Phase
N/A
Intervention
Not specified
Conditions
Acute Pancreatitis
Sponsor
Brigham and Women's Hospital
Enrollment
40
Locations
1
Primary Endpoint
Prevalence (point prevalence) of the systemic inflammatory response syndrome (SIRS) at 24 hours
Status
Terminated
Last Updated
9 years ago

Overview

Brief Summary

Vigorous fluid resuscitation is currently believed to play a key role in reducing complications associated with acute pancreatitis. However, aggressive fluid replacement can be associated with complications such as pulmonary fluid sequestration. The purpose of this study is to evaluate alternative approaches to early fluid resuscitation for patients with acute pancreatitis.

Detailed Description

Primary Aim: Evaluate the impact of a goal-directed fluid resuscitation protocol compared to standard fluid resuscitation on systemic inflammation in patients with acute pancreatitis. Secondary Aim: Evaluate the impact of resuscitation with Lactated Ringer's compared to normal saline on systemic inflammation in acute pancreatitis.

Registry
clinicaltrials.gov
Start Date
March 2009
End Date
June 2010
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Bechien Wu, MD, MPH

Bechien Wu, M.D., M.P.H.

Brigham and Women's Hospital

Eligibility Criteria

Inclusion Criteria

  • acute pancreatitis diagnosed by at least 2 criteria
  • adult patients at least 18 years of age

Exclusion Criteria

  • history of severe cardiovascular, respiratory, renal, hepatic or hematologic/immunologic disease
  • concurrent metabolic or physiologic derangement requiring specific fluid management
  • pregnancy
  • patients transferred from acute care hospital

Outcomes

Primary Outcomes

Prevalence (point prevalence) of the systemic inflammatory response syndrome (SIRS) at 24 hours

Time Frame: first 24 hours of hospitalization

Study Sites (1)

Loading locations...

Similar Trials